Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (33)
Michael Rimmer, Bee K. Tan, Helena Teede, Shakila Thangaratinam & Bassel H. Al Wattar. (2020) Metabolic inflexibility in women with polycystic ovary syndrome: a systematic review. Gynecological Endocrinology 36:6, pages 501-507.
Read now
Read now
M. N. Gunning & B. C. J. M. Fauser. (2017) Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?. Climacteric 20:3, pages 222-227.
Read now
Read now
P. Collins, C. M. Webb, T. J. de Villiers, J. C. Stevenson, N. Panay & R. J. Baber. (2016) Cardiovascular risk assessment in women – an update. Climacteric 19:4, pages 329-336.
Read now
Read now
Shruthi Mahalingaiah & Evanthia Diamanti-Kandarakis. (2015) Targets to treat metabolic syndrome in polycystic ovary syndrome. Expert Opinion on Therapeutic Targets 19:11, pages 1561-1574.
Read now
Read now
Özgür Yilmaz, Calan Mehmet, Sefa Kelekci & Muzaffer Temur. (2015) Association between red blood cell distribution width and polycystic ovary syndrome. Endocrine Research 40:4, pages 181-187.
Read now
Read now
Bülent Demir, Hüseyin Cengiz, Ismail Ungan, Asuman Gedikbasi, Gökhan Karakoç, Esra Demir & Nazan Demir. (2015) The relationship between epicardial adipose tissue thickness and oxidative stress parameters in patients with isolated polycystic ovary syndrome. Gynecological Endocrinology 31:7, pages 531-535.
Read now
Read now
S. A. Yilmaz, A. Kebapcilar, M. Koplay, O. S. Kerimoglu, A. T. Pekin, B. Gencoglu, N. U. Dogan & C. Celik. (2015) Association of clinical androgen excess with radial artery intima media thickness in women with polycystic ovary syndrome. Gynecological Endocrinology 31:6, pages 477-482.
Read now
Read now
Carly E Kelley, Ann J Brown & Tracy L Setji. (2014) Screening for glucose intolerance in polycystic ovary syndrome: hemoglobin A1C, fasting blood glucose or oral glucose tolerance test?. Expert Review of Endocrinology & Metabolism 9:6, pages 671-683.
Read now
Read now
Enrico Carmina. (2014) Polycystic ovary syndrome: Metabolic consequences and long-term management. Scandinavian Journal of Clinical and Laboratory Investigation 74:sup244, pages 23-26.
Read now
Read now
Tulin Bayrak, Polat Dursun, Ahmet Bayrak, Murat Gültekin, Ali Kolusarı, Erdinç Çakır, Merve Ozyurt & Hulusi B. Zeyneloğlu. (2012) Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS. Gynecological Endocrinology 28:11, pages 874-878.
Read now
Read now
Rüya Deveer, Yaprak Engin-Üstün, Sema Uysal, Filiz Akın Su, Seval Sarıaslan, Cavidan Gülerman & Leyla Mollamahmutoğlu. (2012) Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome. Gynecological Endocrinology 28:8, pages 602-605.
Read now
Read now
Malin Gingnell, Ingrid Dahlbom, Åsa Lindholm, Miriam Hudecova, Ragnheidur Arnadottir, Tony Hansson & Inger Sundstrom-Poromaa. (2011) Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women. Gynecological Endocrinology 27:7, pages 486-490.
Read now
Read now
Dorte Glintborg & Marianne Andersen. (2010) An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecological Endocrinology 26:4, pages 281-296.
Read now
Read now
Carolina Fux Otta, Myriam Wior, Gabriel S. Iraci, Raquel Kaplan, Diana Torres, María Isabel Gaido & Eduardo P. Wyse. (2010) Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial. Gynecological Endocrinology 26:3, pages 173-178.
Read now
Read now
Marie-Hélène Massicotte, Fabienne Langlois & Jean-Patrice Baillargeon. (2010) Current procedures for managing polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology 5:1, pages 77-91.
Read now
Read now
Christine Brady, Shaymaa S Mousa & Shaker A Mousa. (2009) Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder. Drug, Healthcare and Patient Safety 1, pages 9-15.
Read now
Read now
E. Carmina. (2009) Cardiovascular risk and events in polycystic ovary syndrome. Climacteric 12:sup1, pages 22-25.
Read now
Read now
Angelique J Goverde, H Egbertine Westerveld, Susanne M Verhulst & Bart CJM Fauser. (2008) Polycystic ovary syndrome as a developmental disorder. Expert Review of Obstetrics & Gynecology 3:6, pages 775-787.
Read now
Read now
Feridun Karakurt, Ilknur Inegol Gumus, Nuket Bavbek, Ayse Kargili, Cemile Koca, Yusuf Selcoki, Mustafa Ozbek, Ali Kosar & Ali Akcay. (2008) Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome. Gynecological Endocrinology 24:9, pages 491-497.
Read now
Read now
Ottar Lunde & Tom Tanbo. (2007) Polycystic ovary syndrome: A follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15–25 years after ovarian wedge resection. Gynecological Endocrinology 23:12, pages 704-709.
Read now
Read now
Catherine J Hayden & Adam H Balen. (2006) Polycystic ovary syndrome and metabolic syndrome. Expert Review of Obstetrics & Gynecology 1:2, pages 183-194.
Read now
Read now
R. Słopień, K. Lewandowski, E. Kolacz, K. Zawilska & A. Warenik-Szymankiewicz. (2006) Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity. Gynecological Endocrinology 22:11, pages 651-654.
Read now
Read now
Sibel Kizkin, Yaprak Engin-Ustun, Yusuf Ustun, Cemal Ozcan, Semih Serbest & Handan Isin Ozisik. (2005) Cerebral artery hemodynamics in polycystic ovary syndrome. Gynecological Endocrinology 21:5, pages 287-291.
Read now
Read now
K Lakhani, GM Prelevic, AM Seifalian, WU Atiomo & P Hardiman. (2004) Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors. Journal of Obstetrics and Gynaecology 24:6, pages 613-621.
Read now
Read now
Paolo Moghetti. (2001) Advances in the treatment of polycystic ovary syndrome. Expert Opinion on Investigational Drugs 10:9, pages 1631-1640.
Read now
Read now
Y. Wang, P. Fedorcsák, P. O. Dale, R. Storeng, T. Åbyholm & T. Tanbo. (2001) Simplification of continuous infusion of glucose with model assessment in the evaluation of insulin resistance in women with PCOS. Gynecological Endocrinology 15:3, pages 192-197.
Read now
Read now
Sarah Wild, Tracey Pierpoint, Howard Jacobs & Paul McKeigue. (2000) Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study. Human Fertility 3:2, pages 101-105.
Read now
Read now
Margareta FridstrÖM, Henry Nisell, Peter SjÖBlom & TorbjÖRn Hillensjo. (1999) Are Women with Polycystic Ovary Syndrome at an Increased Risk of Pregnancy-Induced Hypertension and/or Preeclampsia?. Hypertension in Pregnancy 18:1, pages 73-80.
Read now
Read now
M. Ciampelli & A. Lanzone. (1998) Insulin and polycystic ovary syndrome: A new look at an old subject. Gynecological Endocrinology 12:4, pages 277-292.
Read now
Read now
C. Battaglia, P. G. Artini, A. D. Genazzani, R. Gretnigni, M. Salvatori, M. R. Sgherzi, S. Giulini, M. Lombardo & A. Volpe. (1997) Color Doppler analysis in oligo-and amenorrheic women with polycystic ovary syndrome. Gynecological Endocrinology 11:2, pages 105-110.
Read now
Read now
H. S. Jacobs. (1996) Polycystic ovary syndrome: the present position. Gynecological Endocrinology 10:6, pages 427-433.
Read now
Read now
D. Grisaru, F. Azem, M. Oren, A. Bar-Am, M. Inbar & J. B. Lessing. (1996) A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management. Gynecological Endocrinology 10:5, pages 337-341.
Read now
Read now
S. von Eckardstein, A. von Eckardstein, H.-G. Bender, H. Schulte & G. Assmann. (1996) Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome. Gynecological Endocrinology 10:5, pages 311-318.
Read now
Read now